Pulmonary Rehabilitation in End-Stage Liver Disease
Does Pulmonary Rehabilitation Improve Frailty and Sarcopenia in End Stage Liver Disease?
Sponsor: Mayo Clinic
Terminated
difficulty recruiting
A NA clinical study on End Stage Liver Disease, this trial is terminated or withdrawn. The trial is conducted by Mayo Clinic and has accumulated 13 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Jan 2025 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2022 — Dec 2023 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Recruiting NA
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
-
Dec 2019 — Dec 2020 [monthly]
Recruiting NA
-
Apr 2019 — Dec 2019 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .